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Executive functionDiffusion magnetic resonance imaging is increasingly used as a non-invasive method to investigate white
matter structure in neurological and neuropsychiatric disease. However, many options are available for the
acquisition sequence and analysis method. Here we used Parkinson's disease as a model neurodegenerative
disorder to compare imaging protocols and analysis options. We investigated fractional anisotropy and mean
diffusivity of white matter in patients and age-matched controls, comparing two datasets acquired with dif-
ferent imaging protocols. One protocol prioritised the number of b value acquisitions, whilst the other
prioritised the number of gradient directions. The dataset with more gradient directions was more sensitive
to reductions in fractional anisotropy in Parkinson's disease, whilst the dataset with more b values was more
sensitive to increases in mean diffusivity. Moreover, the areas of reduced fractional anisotropy were highly
similar to areas of increased mean diffusivity in PD patients. Next, we compared two widely used analysis
methods: tract-based spatial statistics identiﬁed reduced fractional anisotropy and increased mean diffusivity
in Parkinson's disease in many of the major white matter tracts in the frontal and parietal lobes. Voxel-based
analyses were less sensitive, with similar patterns of white matter pathology observed only at liberal statis-
tical thresholds. We also used tract-based spatial statistics to identify correlations between a test of executive
function (phonemic ﬂuency), fractional anisotropy and mean diffusivity in prefrontal white matter in both
Parkinson's disease patients and controls. These ﬁndings suggest that in Parkinson's disease there is wide-
spread pathology of cerebral white matter, and furthermore, pathological white matter in the frontal lobe
may be associated with executive dysfunction. Diffusion imaging protocols that prioritised the number of di-
rections versus the number of b values were differentially sensitive to alternative markers of white matter
pathology, such as fractional anisotropy and mean diffusivity.
© 2012 Elsevier Inc. Open access under CC BY license.Introduction
Although Parkinson's disease (PD) is deﬁned by itsmotor syndrome –
akinesia, resting tremor, and rigidity – it is also associated with many
non-motor symptoms and cognitive deﬁcits (Chaudhuri and Schapira,
2009; Kehagia et al., 2010). The diversity of these motor and cognitive
phenomena reﬂects thewidespread progression of underlying patholo-
gy, including alphasynuclein-based Lewy body aggregates, loss of dopa-
minergic projections from the substania nigra to the striatum, andtional anisotropy; FWE, family-
SE, mini-mental state examina-
SS, tract-based spatial statistics;
Parkinson's Disease Rating Scale.
ciences Unit, 15 Chaucer Road,
.L. Rae).
 license.progressive loss of cholinergic and monoaminergic cortical projections
from the forebrain (Braak et al., 2006; Spillantini et al., 1997). Greymat-
ter atrophy occurs in cortical and subcortical regions (Jubault et al.,
2009; Lee et al., 2010a; Nishio et al., 2010; Pereira et al., in press;
Reetz et al., 2009; Rowe et al., 2010; Song et al., 2011). There are also
pathological changes in white matter in the form of Lewy neurites,
which accumulate in brainstem axons and later, in the cerebral white
matter (Braak et al., 2006). However, the extent of whitematter pathol-
ogy in PD, and its impact upon motor and cognitive function, remains
uncertain.
Diffusion tensor imaging (DTI) is an effective non-invasive tool to in-
vestigate pathological changes in thewhitematter of living neurodegen-
erative and psychiatric patients (Acosta-Cabronero et al., 2010; Douaud
et al., 2011; Kubicki and Shenton, 2009; Peran et al., 2010; Wang et al.,
2009). DTI is sensitive to the diffusion of water molecules within neural
tissue (Basser et al., 1994).Watermolecules tend to diffuse longitudinal-
ly along an axonal trajectory, rather than in the perpendicular direction,
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intracellular structures. Scalar measures of diffusion thereby act as
markers forwhitematter tractmicrostructure. Twomeasures commonly
used to assess tract microstructure in health (Scholz et al., 2009) and in
disease (Bodini and Ciccarelli, 2009) are fractional anisotropy (FA) and
mean diffusivity (MD). FA characterises diffusion in the axonal orienta-
tion relative to two orthogonal radial orientations, representing how
strongly directional diffusion is within white matter. MD characterises
themean diffusion along the axonal and radial orientations, representing
how restricted diffusion is within white matter. Reductions in FA or in-
creases in MD are therefore often used as markers of a change in mye-
lination or degradation of axonal structure.
Previous DTI studies have used FA andMD to investigate white mat-
termicrostructure in PD and related disorders (such as PD dementia and
dementia with Lewy bodies). Many have taken a region-of-interest ap-
proach in which structures of interest are manually deﬁned on MR im-
ages (Chan et al., 2007; Gattellaro et al., 2009; Modrego et al., 2011;
Peran et al., 2010; Rolheiser et al., 2011; Vaillancourt et al., 2009). Sever-
al of these region-of-interest studies have identiﬁed reduced FA or in-
creased MD in areas of a priori relevance to PD, such as the substantia
nigra. However,manual region-of-interest comparison of diffusionmea-
sures is subject to inter-rater variability, and moreover, limits the re-
gions in which signiﬁcant group differences can be found.
Whole-brain analysis methods permit group comparisons of diffu-
sion measures outside speciﬁed regions-of-interest. DTI studies of PD
have used voxel-based analyses (Karagulle Kendi et al., 2008; Lee et
al., 2010b; Zhan et al., 2012; Zhang et al., 2011) and skeleton-based
analyses (Hattori et al., 2012; Ibarretxe-Bilbao et al., 2010). These stud-
ies have identiﬁed reduced FA in PD in regions outside the substantia
nigra that have been putatively associatedwith Lewyneurite pathology,
such as the olfactory tract (Ibarretxe-Bilbao et al., 2010; Zhang et al.,
2011), external capsule (Zhan et al., 2012), and prefrontal white matter
(Karagulle Kendi et al., 2008).
However, key questions remain. What is the optimum diffusion im-
aging protocol when imaging PD patients? Given limited imaging time
inmany clinical and research settings, a briefer diffusion sequence is ad-
vantageous with regards to both patients' comfort and data quality (as
subjects will move less). It is therefore important to identify a short dif-
fusion imaging protocol that is sensitive to group differences in diffu-
sion measures between PD patients and controls. The possibility of
large motion artefacts, either from a resting tremor or sudden move-
ments to relieve akinetic-rigidity, should also be considered. A diffusion
imaging protocol incorporating bothmultiple b value acquisitions and a
large number of gradient directions can improve the accuracy of diffu-
sion measures such as FA and MD (Correia et al., 2009). However,
when time is limited, a diffusion imaging protocol must prioritise one
or the other. A larger number of b values per direction can improve
the estimation of diffusivity along each direction, particularly in the
presence of lower signal to noise (which could be the case for example,
if PD patients had greatermotion artefacts). In contrast, a larger number
of gradient directions enablemore accurate spatial reconstruction of the
white matter structure through greater angular resolution. We there-
fore acquired two DTI datasets from the same PD patients and controls,
each with a diffusion imaging protocol prioritising either b values or
gradient directions, to compare the sensitivity of the two protocols
with regards to detection of group differences in diffusion measures.
A second important consideration is the method of analysis of DTI
data. Although whole-brain studies of diffusion measures in PD have
utilised either a voxel- or skeleton-based approach, none of these PD
studies has examined the beneﬁts of one approach over the other. Sever-
al issues have been raised regarding the validity of a voxel-based ap-
proach for DTI data (Smith and Kindlmann, 2009). In particular, one
cannot be certain that the same region of whitematter tract corresponds
accurately across subjects. The tract-based spatial statistics (TBSS)meth-
od aims to solve this correspondence problem by creation of a “mean FA
skeleton”, onto which individual subject FA images are projected beforevoxelwise statistics are performed (Smith et al., 2006). Whilst
maintaining control of tract localisation is important, we also aimed to
determine which of the two methods would be more sensitive to FA or
MD alterations in PD; we therefore repeated the analysis of our two
datasets using both TBSS and voxel-based methods.
Structure–function correlations with diffusionmeasures can be useful
to characterise individual differences and heterogeneity of disease. In the
speciﬁc case of PD, the signiﬁcance of white matter tract microstructure
alterations for motor and cognitive function disease remains unknown.
A patient's score on section III of the Uniﬁed Parkinson's Disease Rating
Scale (UPDRS; Fahn et al., 1987) is commonly used to indicate the level
of motor disability. Two studies have identiﬁed correlations between
UPDRS scores and FA in the substantia nigra (Modrego et al., 2011;
Zhan et al., 2012). However, no associations were found between white
matter tractmicrostructure andmotor function.With regards to cognitive
function, Hattori et al. (2012) correlated mini-mental state examination
(MMSE) scores with FA measures in PD patients. Patients with cognitive
impairment showed a correlation between FA in parietal white matter
and MMSE scores. No correlation was identiﬁed, however, between FA
and MMSE scores for patients with “normal cognition”. Nonetheless, PD
patients with apparently normal cognition (i.e. with a MMSE score that
falls within the normal range of ≥26), may still show speciﬁc deﬁcits in
executive function (Kehagia et al., 2010; Williams-Gray et al., 2007). For
example, phonemic ﬂuency can be impaired in PD, including in non-
demented patients (Mimura et al., 2006; Williams-Gray et al., 2007;
Witt et al., 2006). Therefore we correlated diffusion measures with
motor and executive function in our non-demented sample of PD pa-
tients, using UPDRS and phonemic ﬂuency scores.
This study therefore sought to address the following questions: when
collecting diffusion imaging data and time is limited, which acquisition
parameters should be prioritised? Are voxel-based or skeleton-based
analyses more sensitive to group differences in FA and MD? What is
the extent of white matter pathology in early to mid stage PD? Finally,
is such white matter pathology related to patients' motor and cognitive
function?
Methods
Subjects
Fourteen patients with idiopathic PD were recruited from the Cam-
bridge Centre for Brain Repair's PD research clinic, and met the criteria
for diagnosis of Parkinson's disease according to the UK PD Brain Bank
criteria (Hughes et al., 1992). Patientswere in an early tomid stage of dis-
ease, according to the Hoehn and Yahr system (H&Y, Hoehn and Yahr,
1967) (stages 1.5 to 3, none in stage 4 or 5). A neurologist experienced
in movement disorders (JBR) undertook the UPDRS-III motor subscale
and H&Y rating scale prior to scanning on all patients. Patients were not
demented, based on the clinician review at their most recent clinic as-
sessment and corroborated by a within-study score of 26/30 or more
on the mini-mental state examination (MMSE, Folstein et al., 1975). Fif-
teen neurologically healthy age-matched controls were recruited from
the Medical Research Council Cognition and Brain Sciences Unit volun-
teer panel. All subjects undertook a phonemic ﬂuency test (number of
words beginningwith ‘p’ in 1 min) (Benton, 1968). See Table 1 for subject
demographic and neuropsychological evaluation information, and pa-
tient disease severity information. Details of patients' medications and
doses are contained within the Supplementary information. All subjects
gave informedwritten consent in accordancewith theDeclaration ofHel-
sinki. The study was approved by the Local Research Ethics Committee.
Diffusion magnetic resonance image acquisition and pre-processing
Two sets of diffusion-weighted data were collected from subjects
on separate scanning days, as part of a study in which patients were
scanned once whilst taking their normal dopaminergic medication,
Table 1
Demographic and neuropsychological evaluation information for PD patients and con-
trols, and disease severity information for PD patients. Mean (range). UPDRS = Uniﬁed
Parkinson's Disease Rating Scale (subscale III).
PD patients
(n=14)
Controls
(n=15)
Statistic
p-value
Male/female 7/7 10/5 0.36a
Age 65 (51:78) 64 (50:75) 0.71b
Phonemic ﬂuency score 14.57 (11:24) 15 (7:21) 0.81b
Mini-mental state examination 28.36 (26:30) 29 (26:30) 0.14b
Disease duration (years) 10 (4:20) – –
UPDRS on 10 (3:19) – –
UPDRS off 20 (14:32) – –
Hoehn and Yahr on 1.9 (1:3) – –
Hoehn and Yahr off 2.1 (1.5:3) – –
L-dopa equivalent daily dose
(mg)
1388 (540:2160) – –
a x2 test.
b t-test.
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lected an average of 22 days (3 weeks) apart (minimum between scan
duration: 11 days, maximum: 42 days), and were counterbalanced for
patients being on- or off-medication. On both scanning sessions, twice
refocused spin echo diffusion-weighted images were acquired on a Sie-
mens Trio 3T, with a voxel size of 2×2×2 mm³ (2 mm interleaved axial
slices; matrix size 96×96; ﬁeld of view 192×192 mm).
In one dataset (“12×5”), diffusion-weighting was applied along 12
gradient directions, with 5 acquisitions, one acquisition at each of the fol-
lowing b values: 250 s/mm², 500 s/mm, 750 s/mm², 950 s/mm², and
1200 s/mm². 6 images with no diffusion-weighting (b=0 s/mm²) were
acquired throughout the sequence. In the second dataset (“30×2”),
diffusion-weighting was applied along 30 gradient directions, with 2 ac-
quisitions, one at a b value of 600 s/mm², and the other at 1200 s/mm². 5
images with no diffusion-weighting (b=0 s/mm²) were acquired
throughout the sequence. For both protocols, the gradient directions
were optimised according to criteria described by Jones et al. (1999).
Each diffusion imaging protocol took approximately 10 min.
Data were preprocessed and analysed using FMRIB Software Library,
version 4.1 (FSL; www.fmrib.ox.ac.uk/fsl). Diffusion-weighted images
were converted from dicom to nifti format, and corrected for eddy cur-
rents and subject motion by afﬁne registration to the ﬁrst b0 image
using the FSL “eddy_correct” function. Each subject's movement in x,
y and z co-ordinates was calculated according to the output of
eddy_correct. Diffusion tensors were linearly ﬁtted to the diffusion-
weighted images using the FSL tool “dtiﬁt”, giving output maps of
FA, MD, AD (axial diffusivity) and RD (radial diffusivity).
To determine whether PD patients' movements during image acqui-
sition were greater than controls', a measure of volume-to-volume dis-
placement was obtained for each subject using the output logﬁle of the
“eddy_correct” motion correction function. From the “eddy_correct”
logﬁle, we took the translation measurement in x, y, and z co-ordinates
between each volume, and then calculated the root mean square of the
three translations. We summed this measure across all the volumes to
give an index of the total displacement translations (the path length in
three dimensions) throughout the sequence acquisition. This index was
taken as a measure of subject motion during the 10 min diffusion se-
quence. Rotations and translations are highly correlated during scanning,
and thereforewe did not include a rotation factor in our summarymetric
of movement. A repeated measures analysis of variance with a within-
subjects factor of imaging protocol (12×5 or 30×2) and between-
subjects factor of subject group (PD patient or control) indicated wheth-
er PD patients had signiﬁcantly worse motion than control subjects.
Tract-based spatial statistics
The FSL tool “TBSS” (Tract-based spatial statistics) (Smith et al.,
2006) was used to compare diffusion measures between PD patientsand controls, to correlate diffusion measures with motor and cogni-
tive function, and to compare between the two datasets acquired
using the different diffusion imaging protocols. Subjects' individual
FA images were ﬁrst registered to a common template. As PD is a neu-
rodegenerative disease, some degree of atrophy is often present,
which can result in enlarged ventricles. With normal ageing, there
can also be atrophy and enlargement of the ventricles. Registration
to a study-speciﬁc image was chosen with the aim of more accurate
alignment of the centre of tracts across subjects. Subjects' FA images
were therefore registered to the FA image of the most “representa-
tive” subject, which is automatically detected by TBSS according to
which image requires the least transformation to the FA images of
all other subjects (in this instance, the FA image of a control from
the 30×2 dataset). After subjects' individual FA images were regis-
tered to this initial template, they were registered to MNI152 space
for convenience of display and reporting. The mean FA skeleton, a
representation of the centre of the white matter tracts common to
all subjects, was created and thresholded at FA>0.25. Subjects'
MNI152-registered FA images were projected onto the skeleton be-
fore statistics were performed on each skeleton voxel using permuta-
tions testing with the FSL tool “randomise”. A similar process was
performed for the MD, AD, and RD images, without the initial regis-
trations: the MD, AD, and RD images were projected onto the same
skeleton, and statistics performed with randomise.
A design matrix was generated using the FSL tool “Glm”, in which
imageswere categorised according to subject group (PD patient or con-
trol) and imaging protocol (12×5 or 30×2). The repeatedmeasures el-
ement of the design was speciﬁed using the “group” option in the Glm
tool. White matter microstructure changes with age (Salat et al.,
2009). In this study, a primary aim was to search for evidence of
white matter pathology related to PD, and not due to age-related
change. Subject age was therefore entered into the design matrix as a
confounding covariate, for each group separately. Gender was addition-
ally entered as a confounding covariate for the two groups together
(any gender difference in white matter microstructure is assumed to
be similar in PD patients and controls). UPDRS scores off-medication
were entered as a covariate of interest, to establish if white matter
pathology correlates with severity of motor symptoms. Phonemic
ﬂuency scores for both PD patients and controls were also entered as
a covariate of interest, to investigate whether white matter microstruc-
ture correlates with executive function. All covariates except gender
were demeaned before values were entered.
This designmatrix was used to analyse subjects' FA, MD, AD, and RD
images using the FSL tool randomise, with 5000 permutations. The
randomise option threshold-free cluster enhancement (TFCE, Smith
and Nichols, 2009) was applied. All statistic images were corrected for
multiple comparisons and thresholded at pb0.01. Any regions on the
skeleton showing signiﬁcant clusters were localised using the “John
Hopkins University ICBM-DTI-81 White Matter Labels” and “John
Hopkins University White Matter Tractography” atlases in FSL.
To validate accurate registration to the study-speciﬁc template in the
ﬁrst step of TBSS, the TBSS function “deproject” was used to transform
any signiﬁcant statistic images generated by the voxelwise statistics
back to native subject space. There were no signiﬁcant voxels in any of
the contrasts that showed deviation from white matter when dep-
rojected back to native subject space, thus suggesting that any signiﬁcant
ﬁndings cannot be attributed to mis-registration. See Supplementary in-
formation for images from a sample signiﬁcant statistic image (FA C>PD
30×2; the statistic with the largest number of signiﬁcant voxels) dep-
rojected back into each subject's native space.
Voxel-based analyses
A study-speciﬁc FA templatewas created using the FA images from all
subjects (Abe et al., 2010). First, all subjects' FA images were coregistered
to the standard space FA template provided by FSL (FMRIB58_1mm)
Fig. 1. TBSS: regions of reduced FA (pb0.01 corrected) in PD patients in A) the 12×5 dataset, and B) 30×2 dataset, and increased MD (pb0.01 corrected) in C) the 12×5 and D) 30×2
datasets. TBSS results are shown overlaid on an MNI152 template and the mean FA skeleton (green).
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transformation. The resulting normalised FA imageswere then smoothed
with an 8 mm isotropicGaussian kernel, and amean image (FA template)
was created. Individual subjects' FA images were then registered to the
customised FA template using FSL registration tools.
All subsequent steps for voxel-based analysis were performed using
the SPM8 package (www.ﬁl.ion.ucl.ac.uk/spm). The transformed FA im-
ages were smoothed with Gaussian kernels with full width half maxi-
mum of 4 mm. A general linear model included subject group (PD
patient or control) as a factor, plus age and gender as confounding vari-
ables, and UPDRS scores and phonemic ﬂuency as covariates of interest
(thus resembling the TBSS model above). Statistically signiﬁcant differ-
ences in FA and MD between PD patients and controls were assessed
with a repeated measures analysis of variance. In addition, all tests on
FA were performed using an absolute threshold of FA>0.2, such that if
a voxel had an FA value of less than 0.2 in any one subject, that voxel
was not considered for analysis. These thresholds help to minimise thecomparison of different structures in different subjects and to constrain
the total number of voxels to be analysed. An initial threshold p-value
of b0.01 (one-tailed) corrected with familywise error (FWE) rate and a
cluster size greater than 50 voxels was considered to be statistically sig-
niﬁcant. An exploratory threshold (pb0.001 uncorrected) is also
reported.
Results
Neuropsychological scores
PD patients were well matched to controls for age and gender
(Table 1). They had normal scores on the mini-mental state examina-
tion (t=1.52, p=0.14, mean PD=28.36, mean control=29; no sub-
jects with a score below 26). Their phonemic ﬂuency scores did not
differ from controls' (t=0.24, p=0.81, mean PD=14.57, mean
control=15).
Table 2
Tracts with reduced FA or increased MD (pb0.01 corrected) in PD patients in the 12×5
and 30×2 datasets, localised according to the John Hopkins University ICBM-DTI-81
White Matter Labels and John Hopkins University White Matter Tractography atlases
in FSL (B = bilateral; L = left hemisphere, R = right hemisphere).
Tract FA MD
12×5 30×2 12×5 30×2
Forceps minor B B B B
Corpus callosum B B B B
Forceps major B B L –
Anterior thalamic radiation R B B B
Uncinate fasciculus B B B B
Inferior fronto-occipital fasciculus B B B B
Internal capsule – – L –
External capsule – – B –
Corticospinal tract R B L –
Superior longitudinal fasciculus R B B –
Inferior longitudinal fasciculus – B L –
Total n of voxels at pb0.01 6395 20771 15403 1617
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In a repeated measures analysis of variance, there was no signiﬁ-
cant main effect of group (PD patient or control) on total amount of
movement during scanning (F=0.05, p=0.82). There was no signif-
icant interaction between group and imaging protocol (F=0.61,
p=0.44). Thus the total amount of subject movement throughout
the two sequence acquisitions did not differ between PD patients
and controls. The main effect of imaging protocol was also not signif-
icant (F=0.108, p=0.744), indicating that motion artefacts were no
worse during one imaging protocol than the other. See Supplementa-
ry information for mean total amount of subject movement by PD pa-
tients and controls during each of the two imaging sequences.
Tract-based spatial statistics
PD patients had reduced FA, and increased MD, in widespread re-
gions of cerebral white matter (see Fig. 1). However, there were differ-
ences in the extent of the reductions in FA and increases in MD in the
two datasets acquired with different diffusion imaging protocols. Both
the 12×5 and 30×2 datasets identiﬁed reduced FA (pb0.01) in PD pa-
tients in prefrontal and parietal white matter, the corpus callosum, and
the superior corticospinal tract; both datasets identiﬁed increased MD
(pb0.01) in prefrontal white matter and the corpus callosum.
However, the 30×2dataset identiﬁed amuch larger number of voxels
showing a reduction in FA in PD patients in prefrontal and parietal white
matter, the corpus callosum, and superior corticospinal tract than the
12×5 dataset. Additionally, the 30×2 dataset also identiﬁed reductions
in FA in temporal lobe white matter. The 12×5 dataset, in contrast,Fig. 2. TBSS: UPDRS off score correlates negatively (pb0.01 corrected) with FA in the right sp
and the mean FA skeleton (green).identiﬁed increases in MD (pb0.01) in parietal and temporal lobe white
matter, in the left mid- and superior corticospinal tract, and the internal
and external capsules, changes that were not found in the 30×2 dataset.
Table 2 lists all tracts identiﬁed as having reduced FA or increased MD in
PD patients in each dataset. There were increases in AD and RD in many
of the regions showing reductions in FA and increases in MD (see Fig. S2
in Supplementary information). Therewere no regions of increased FA or
decreased MD (pb0.01) in PD patients in either of the two datasets.
Although the 30×2 dataset identiﬁed more widespread reductions
in FA in PD patients, and the 12×5 dataset more widespread increases
in MD, the interaction between subject group and imaging protocol
did not reveal any signiﬁcant differences between protocols, for either
FA orMD (pb0.01). Thus although the 30×2 sequence wasmore sensi-
tive to group differences in FA, and the 12×5 sequence more sensitive
to differences in MD, they were not signiﬁcantly different from each
other in a direct comparison.
Motor severity
In the 30×2 dataset, as the severity of patients' motor features
(UPDRS off medication score) increased, FA decreased in the right
splenium and right forceps major (pb0.01). No correlations with
UPDRS score at pb0.01 were identiﬁed in the 12×5 dataset for FA,
or in either of the two datasets for MD (see Fig. 2).
Executive function
In both PD patients and controls, we found that as phonemic ﬂuency
score increased, FA increased (pb0.01) and MD decreased (pb0.01) in
prefrontal white matter and the anterior corpus callosum. Both 12×5
and 30×2 datasets additionally identiﬁed correlations between phone-
mic ﬂuency score and FA in the right internal capsule, and the 12×5
dataset showed further correlations between phonemic ﬂuency and
FA in the external capsules. Table 3 lists all tracts inwhich FA orMD cor-
related with phonemic ﬂuency scores in PD patients and controls.
Voxel-based analyses
At a signiﬁcance threshold of pb0.01 corrected for multiple compar-
isons, there were no signiﬁcant clusters of reduced FA or increased MD
in PD patients. However, at amore liberal exploratory statistical thresh-
old of pb0.001 (uncorrected), we observed a similar pattern of white
matter alterations to that identiﬁed by the TBSS analysis: namely that
both the 12×5 and 30×2 datasets identiﬁed reduced FA in PD patients
in prefrontal white matter, parietal white matter, and the corpus cal-
losum; and increased MD in prefrontal and parietal white matter (see
Fig. 4). As in the TBSS analysis, at this lower statistical threshold the
30×2 dataset identiﬁed more extensive reductions in FA, including
temporal lobe white matter, the left external capsule, and the leftlenium and forceps major in the 30×2 dataset, shown overlaid on an MNI152 template
Table 3
Tracts with correlations between increased FA or decreased MD and phonemic ﬂuen-
cy (pb0.01 corrected) in PD patients and controls, in the 12×5 and 30×2 datasets,
localised according to the John Hopkins University ICBM-DTI-81 White Matter Labels
and John Hopkins University White Matter Tractography atlases in FSL (B = bilateral;
L = left hemisphere, R = right hemisphere).
Tract FA MD
12×5 30×2 12×5 30×2
Forceps minor B B – B
Corpus callosum B B B B
Forceps major – – – –
Anterior thalamic radiation B R – B
Uncinate fasciculus B R L B
Inferior fronto-occipital fasciculus B R L B
Internal capsule R R – –
External capsule B – – –
Corticospinal tract – – – –
Superior longitudinal fasciculus R – L L
Inferior longitudinal fasciculus – – – –
Total n of voxels at pb0.01 4426 1979 1303 2060
1680 C.L. Rae et al. / NeuroImage 62 (2012) 1675–1684cerebellum; whilst the 12×5 dataset additionally identiﬁed increased
MD in temporal lobe white matter, the corpus callosum, and the
brainstem.Discussion
There are extensive changes in cerebral white matter in PD. We
found that early to mid stage (Hoehn and Yahr 1–3) non-demented
PD patients have both reduced FA and increased MD across several re-
gions of cerebral white matter. These areas include major white matter
tracts in the frontal and parietal lobes. Although the changes in FA and
MD had a similar spatial distribution, the dataset acquired with more
gradient directions appeared to be more sensitive to reductions in FA,
whilst the dataset acquired with more b values appeared to be more
sensitive to increases in MD (although the direct comparison between
the two datasets was not signiﬁcant). Whilst TBSS identiﬁed these
widespread alterations in PD white matter microstructure at an appro-
priately corrected statistical threshold, a voxel-based approachwas suc-
cessful only when a more liberal uncorrected threshold was used. With
regards to the impact of white matter pathology on cognition, FA andFig. 3. TBSS: regions where phonemic ﬂuency correlates positively (pb0.01 corrected) with
with MD in C) the 12×5 and D) 30×2 datasets, shown overlaid on an MNI152 template anMD in prefrontal white matter correlated with phonemic ﬂuency, an
index of executive function.
Although previous region-of-interest diffusion studies of PD have
shown reduced FA in speciﬁed subcortical structures and cerebral
white matter tracts (Chan et al., 2007; Gattellaro et al., 2009; Modrego
et al., 2011; Peran et al., 2010; Rolheiser et al., 2011; Vaillancourt et al.,
2009), our results demonstrate more spatially extensive white matter
pathology in PD than previously identiﬁed in these studies.We have rep-
licated previous ﬁndings usingwhole-brain analysis methods (Hattori et
al., 2012; Ibarretxe-Bilbao et al., 2010; Karagulle Kendi et al., 2008; Lee et
al., 2010b; Zhan et al., 2012; Zhang et al., 2011),ﬁnding reduced FA in the
gyrus rectus (olfactory tract), prefrontal white matter, and the
corticospinal tract. Here, we also identiﬁed reductions in FA in prefrontal,
parietal and temporal lobe white matter, throughout the length of the
corpus callosum, and in the mid- and superior corticospinal tract. In-
creases in MD, similarly a marker of white matter pathology, were
found in prefrontal, parietal and temporal white matter, the corpus cal-
losum, in the mid- and superior corticospinal tract, and the internal
and external capsules. Together, our results suggest that many regions
of cerebral white matter are affected in PD, even in early to mid motor
stage patients.
It is difﬁcult tomake speciﬁc inferences as to the underlying axonal or
myelin pathology related to changes in FA andMDusing DTI alone. It has
been suggested that changes in the ﬁrst tensor eigenvalue, or axial diffu-
sivity (AD), might be related to axonal pathology (such as reduced axo-
nal density or calibre), whilst changes in the second and third tensor
eigenvalues, or radial diffusivity (RD), might be related tomyelin pathol-
ogy (Song et al., 2002). We did indeed ﬁnd increases in both the AD and
RD at pb0.01 in many of the regions of white matter identiﬁed in the FA
and MD statistics as showing pathology in PD patients (see Supplemen-
tary information). However, Wheeler-Kingshott and Cercignani (2009)
argue that increases in AD or RD should not be over-interpreted for evi-
dence of speciﬁc axonal or myelin pathology. Therefore we do not draw
speciﬁc conclusions as to the particular nature of the pathology underly-
ing the FA and MD changes in PD identiﬁed here.
It is well established that a fronto-striatal dysexecutive syndrome,
accompanied by greymatter pathology affecting fronto-striatal circuits,
can be present from the early stages of PD (Foltynie et al., 2004; Lee et
al., 2010a; Nishio et al., 2010; Owen et al., 1992, 1993; Song et al.,
2011; Williams-Gray et al., 2007, 2009). Here, we have demonstrated
corresponding evidence for fronto-striatal white matter pathology,FA in A) the 12×5 and B) 30×2 datasets; and correlates negatively (pb0.01 corrected)
d the mean FA skeleton (green).
Fig. 4. Voxel-based analysis: Regions of reduced FA in PD patients in A) the 12×5 dataset and B) 30×2 dataset, and increased MD in C) the 12×5 and D) 30×2 datasets, shown at a
liberal threshold of pb0.001 uncorrected with cluster size threshold >50 voxels.
1681C.L. Rae et al. / NeuroImage 62 (2012) 1675–1684with reduced FA and increased MD in prefrontal white matter tracts,
and increased MD in the external capsules (one of the principal white
matter tracts connecting the prefrontal cortex and the striatum).
Phonemic ﬂuency was not impaired in the patient group as a
whole. However, we observed correlations between FA and MD in
prefrontal white matter tracts and subjects' phonemic ﬂuency scores.
FA in the external capsules also correlated with phonemic ﬂuency.
Taken together, these results suggest that fronto-striatal white matter
tract microstructure, considerably altered in PD, is related to execu-
tive function. Pathology in fronto-striatal white matter may be a po-
tential contributing factor to the PD dysexecutive syndrome.
Patients' UPDRS scores correlated with FA in the right splenium of
the corpus callosum. However, that there were not more extensive
correlations with UPDRS scores indicates that the widespread pathol-
ogy identiﬁed by the main group difference is present across a range
of motor severities. We note however that our study included only
patients in an early to mid stage of the disease, using the Hoehn
and Yahr staging system that is based on motor signs, mobility andbalance. The patients varied widely in their duration of illness, and
cognitive function, which are not reﬂected in the staging system.
We asked whether two diffusion imaging protocols would differ in
their sensitivity to white matter tract alterations in PD: one prioritising
gradient directions, the other having fewer directions but a larger range
of b values in the same total scan time (10 min). We did not compare
multiple acquisitions using a single b value with multiple acquisitions
using a range of b values. Given the possibility of larger motion artefacts
in the patient group, we also considered whether improved estimation
of diffusivity per direction, derived from multiple b values, was impor-
tant. In fact, PD patients moved no more during either of the two 10-
minute diffusion image acquisitions than controls. Thus, thismotivation
for a diffusion imaging protocol with a large number of b values was
found to be unsubstantiated.
The two protocols revealed contrasting beneﬁts with regards to
detection of group differences in FA and MD. Previous work with sim-
ulated data suggested that a 12×5 protocol with multiple b values
might beneﬁt accurate estimation of MD, whilst a 30×2 protocol
1682 C.L. Rae et al. / NeuroImage 62 (2012) 1675–1684with a larger number of gradient directions might improve the esti-
mation of FA (Correia et al., 2009). The simulations also indicated
that for tissues with a range of diffusivities (as in the brain), and
lower signal to noise, a diffusion imaging protocol with multiple b
values is likely to give more accurate measures of MD (Correia et al.,
2009). Although the estimation of FA may also beneﬁt from multiple
b values, the number of gradient directions was found to be more im-
portant. A larger number of gradient directions give greater angular
resolution, which facilitates the calculation of relative diffusion in or-
thogonal axonal and radial orientations, underlying the estimation of
FA.Whilst we cannot infer greater accuracy of estimation of FA or MD,
we found that the two sequences differed in sensitivity to white mat-
ter pathology in PD: the 12×5 dataset identiﬁed more widespread in-
creases in MD, whilst in contrast, the 30×2 dataset identiﬁed more
widespread reductions in FA. Despite these differences between pro-
tocols, it is striking that the regional changes in FA identiﬁed by the
30×2 dataset and in MD by the 12×5 dataset overlap considerably
(see Fig. 1). This suggests that given an appropriate diffusion imaging
protocol, similar regions of white matter pathology can be identiﬁed
in both FA and MD maps.
Despite the apparent differences in thresholded statistics, the two
imaging protocols were not signiﬁcantly different from each other in a
direct comparison (as there were no signiﬁcant interactions between
group and diffusion imaging protocol for FA or MD). The difference be-
tween the two imaging protocols in detection of group differences in FA
and MD must therefore be viewed cautiously (Nieuwenhuis et al.,
2011). In addition, the correlations between phonemic ﬂuency and FA
or MD do not suggest that the 30×2 protocol is more sensitive to FA
correlations with phonemic ﬂuency, or the 12×5 protocol to MD corre-
lations. In fact, a small number of skeleton voxels showed the opposite
relationship for correlationwith phonemicﬂuency. However, the differ-
ence in sensitivity to the phonemic ﬂuency correlations for the two pro-
tocols is relatively small (see Fig. 3 and Table 3), approximately 1000–
2500 voxels. This contrasts with the marked difference in sensitivity
to the main group difference for the two protocols (see Fig. 1 and
Table 2), at approximately 14,000 voxels. The different sensitivity of
the two protocols to FA andMDcorrelationswith ﬂuencymust be inter-
preted with caution, given the lack of signiﬁcance of the direct compar-
isons, the comparable ﬂuency between groups, and that the regions
with signiﬁcant correlations overlap rather than segregate. Overall, we
therefore place greater emphasis on commonality of these correlations
with ﬂuency, and the greater sensitivity of group effects to FA through
more directions, rather than the marginal advantage for correlations
with FA through more b values.
TBSS was successful in identifying widespread group differences in
FA andMD between PD patients and controls, and in identifying associ-
ations between cognition and white matter microstructure. A voxel-
based approach, however, was less sensitive, and identiﬁed group dif-
ferences only at a more liberal statistical threshold with no correction
for multiple comparisons. Bearing in mind this caveat, the voxel-based
analysis showed a highly similar pattern of white matter pathology in
PD to the TBSS analysis, namely reductions in FA and increases in MD
in the prefrontal, parietal and temporal white matter, the corpus cal-
losum, external capsules, and the corticospinal tract. As in the TBSS
analysis, voxel-basedmethods showedmore widespread FA reductions
in the 30×2 dataset, whilst the 12×5 dataset showedmorewidespread
MD increases. The corroboration of the TBSS and voxel-based results
suggests that the TBSS results were not obtained merely as a conse-
quence of mis-registration artefacts.
Our results suggest that TBSS can be a more sensitive method than
VBM when comparing diffusion measures in PD patients and controls.
We used the appropriate standard statistical correction methods for
TBSS and VBM respectively, to ensure our procedures were commensu-
rate with common practice. It is therefore difﬁcult to establish whether
the beneﬁt of TBSS is obtained frommore accurate alignment of the cen-
tre of white matter tracts through the registration and skeletonisationprocess, from non-parametric statistics, from the speciﬁc threshold-free
cluster enhancement method, or a combination of these differences.
However, our aim was to investigate whether the TBSS or VBM proce-
dures as a whole differed in sensitivity to white matter pathology in PD.
Wehope that in doing so, ourﬁndingswill be of beneﬁt to othermembers
of the neuroimaging community conducting similar patient–control com-
parisons, as well as stimulating further research into the critical factors
underlying sensitive group comparisons of DTI data.
Despite the demonstration of considerable white matter patholo-
gy in PD, there are some limitations to our study. Firstly, diffusion
data were collected as part of a larger PD study in which patients
were scanned once whilst taking their normal dopaminergic medica-
tion, and once after medication delay. However, it is unlikely that the
medication contributes to the differences in diffusion measures, for
several reasons. The pharmacological action of these drugs makes
an effect on DTI data a priori less likely than a primary effect of dis-
ease. Importantly, post hoc analysis conﬁrmed that the L-dopa dose
equivalent did not correlate with FA or MD. In addition, the two diffu-
sion datasets were counterbalanced for patients being on- or off-
medication, so the contribution of medication status to the protocol
differences observed for FA and MD was minimised. A second limita-
tion is that our scan order was not fully counterbalanced with regards
to the two diffusion imaging protocols. However, measurable differ-
ences from signiﬁcant degeneration are unlikely to have occurred
during our mean scan time interval of 3 weeks. Moreover, the differ-
ential sensitivities of the two datasets to FA and MD cannot be
explained by disease progression during this interval. Thirdly, al-
though the numbers of our subjects (14 PD patients, 15 controls)
are comparable to several other DTI studies of PD, some studies
have used much larger groups of subjects, reducing type II error
(Chan et al., 2007; Hattori et al., 2012; Peran et al., 2010; Zhang et
al., 2011). Nevertheless, we have controlled tightly for type I error,
and demonstrated large group differences between PD patients and
controls in both the 12×5 and 30×2 datasets with fourteen PD pa-
tients and ﬁfteen controls.
It should also be noted that whereas we followed currently standard
practices in the acquisition, pre-processing and analysis of the data, for
both TBSS and VBM, these methods make a number of assumptions
and caveats (see review by Jones and Cercignani, 2010). For example,
we used a linear estimation of the diffusion tensor, and assume Gaussian
noise. This tensor ﬁt may be appropriate at lower b values (1200 s/mm2
or less, as in this study) but not at high b values (3000 s/mm2 or more,
Jones and Basser, 2004). Such higher b values may become more com-
monwith the development of high-angular-resolution diffusion imaging
for enhanced tractography. In addition, a common objection to whole-
brain analysismethods of diffusionmeasures is that as a result of the reg-
istration process, one cannot be certain that the location identiﬁed by
voxelwise statistics as showing a signiﬁcant groupdifference corresponds
to the same anatomical region, or indeed, to white matter at all, in each
subject's native space. To address this concernwe used the TBSS function
“deproject” to validate the registration process by deprojecting any gen-
erated statistic images showing regions of signiﬁcance back to individual
native space, and visually inspecting each deprojected statistic image.
This conﬁrmed that all regions showing signiﬁcant group differences or
associations with cognitive or motor function in the TBSS analysis cor-
responded to white matter in each subject.
Future work might examine the impact that the widespread white
matter pathology in PD identiﬁed here has upon network function of
the brain. The diversity of motor and cognitive features associated
with PD is likely linked to a combination of both local grey matter
dysfunction, and white matter connectional pathology. Such a combi-
nation of pathology may be associated with the impairment in PD of
fronto-striatal networks essential for normal cognitive and motor
function. Future approaches could jointly characterise the pathology
of such networks structurally and functionally in PD, for example by
combining tractography and effective connectivity analyses.
1683C.L. Rae et al. / NeuroImage 62 (2012) 1675–1684Conclusions
We found that white matter pathology is widespread in PD, but is
most marked in the frontal lobes. Furthermore, white matter pathol-
ogy in fronto-striatal networks may be a contributing factor to the PD
dysexecutive syndrome. Our comparison of different acquisition pro-
tocols with which to collect diffusion imaging data in patients, and
evidence that TBSS is more sensitive than voxel-based analysis, will
be of use to researchers wishing to conduct future DTI studies.
Funding
This work was supported by the Wellcome Trust [088324 to JBR,
LEH, EA]; the Medical Research Council UK [MMC; Doctoral Training
Award to CLR; and MC_A060_5PQ30]; Parkinson's UK [RAB]; and
the National Institute for Health Research Cambridge Comprehensive
Biomedical Research Centre.
Acknowledgments
We thank Mark Jenkinson at FMRIB, University of Oxford, for FSL
script on subject motion.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.neuroimage.2012.06.012.
References
Abe, O., Takao, H., Gonoi, W., Sasaki, H., Murakami, M., Kabasawa, H., Kawaguchi, H.,
Goto, M., Yamada, H., Yamasue, H., Kasai, K., Aoki, S., Ohtomo, K., 2010. Voxel-
based analysis of the diffusion tensor. Neuroradiology 52, 699–710.
Acosta-Cabronero, J.,Williams, G.B., Pengas, G., Nestor, P.J., 2010. Absolute diffusivities deﬁne
the landscape of whitematter degeneration in Alzheimer's disease. Brain 133, 529–539.
Basser, P.J., Mattiello, J., LeBihan, D., 1994. MR diffusion tensor spectroscopy and imag-
ing. Biophys. J. 66, 259–267.
Benton, A.L., 1968. Differential behavioral effects in frontal lobe disease. Neuropsychologia
6, 53–60.
Bodini, B., Ciccarelli, O., 2009. Diffusion MRI in neurological disorders. In: Johansen-
Berg, H., Behrens, T.E.J. (Eds.), Diffusion MRI. Academic Press, London, pp. 175–204.
Braak, H., Bohl, J.R., Muller, C.M., Rub, U., de Vos, R.A., Del Tredici, K., 2006. Stanley Fahn
Lecture 2005: The staging procedure for the inclusion body pathology associated
with sporadic Parkinson's disease reconsidered. Mov. Disord. 21, 2042–2051.
Chan, L.L., Rumpel, H., Yap, K., Lee, E., Loo, H.V., Ho, G.L., Fook-Chong, S., Yuen, Y., Tan,
E.K., 2007. Case control study of diffusion tensor imaging in Parkinson's disease.
J. Neurol. Neurosurg. Psychiatry 78, 1383–1386.
Chaudhuri, K.R., Schapira, A.H., 2009. Non-motor symptoms of Parkinson's disease: do-
paminergic pathophysiology and treatment. Lancet Neurol. 8, 464–474.
Correia, M.M., Carpenter, T.A., Williams, G.B., 2009. Looking for the optimal DTI acqui-
sition scheme given a maximum scan time: Are more b-values a waste of time?
Magn. Reson. Imaging 27, 163–175.
Douaud, G., Jbabdi, S., Behrens, T.E., Menke, R.A., Gass, A., Monsch, A.U., Rao, A.,
Whitcher, B., Kindlmann, G., Matthews, P.M., Smith, S., 2011. DTI measures in
crossing-ﬁbre areas: increased diffusion anisotropy reveals early white matter al-
teration in MCI and mild Alzheimer's disease. Neuroimage 55, 880–890.
Fahn, S., Elton, R.L., UPDRS Development Committee, 1987. Uniﬁed Parkinson's Disease
Rating Scale. In: Fahn, S., Marsden, C.D., Caine, D.B., Goldstein, M. (Eds.), Recent De-
velopments in Parkinson's Disease. Macmillan, Florham Park, NJ, pp. 153–163.
Folstein, M.F., Folstein, S.E., McHugh, P.R., 1975. “Mini-mental state”. A practical method for
grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189–198.
Foltynie, T., Brayne, C.E., Robbins, T.W., Barker, R.A., 2004. The cognitive ability of an incident
cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 127, 550–560.
Gattellaro, G., Minati, L., Grisoli, M., Mariani, C., Carella, F., Osio, M., Ciceri, E., Albanese,
A., Bruzzone, M.G., 2009. White matter involvement in idiopathic Parkinson dis-
ease: a diffusion tensor imaging study. AJNR Am. J. Neuroradiol. 30, 1222–1226.
Hattori, T., Orimo, S., Aoki, S., Ito, K., Abe, O., Amano, A., Sato, R., Sakai, K., Mizusawa, H.,
2012. Cognitive status correlates with white matter alteration in Parkinson's dis-
ease. Hum. Brain Mapp. 33, 727–739.
Hoehn, M.M., Yahr, M.D., 1967. Parkinsonism: onset, progression and mortality. Neu-
rology 17, 427–442.
Hughes, A.J., Daniel, S.E., Kilford, L., Lees, A.J., 1992. Accuracy of clinical diagnosis of id-
iopathic Parkinson's disease: A clinico-pathological study of 100 cases. J. Neurol.
Neurosurg. Psychiatry 55, 181–184.
Ibarretxe-Bilbao, N., Junque, C., Marti, M.J., Valldeoriola, F., Vendrell, P., Bargallo, N.,
Zarei, M., Tolosa, E., 2010. Olfactory impairment in Parkinson's disease and whitematter abnormalities in central olfactory areas: A voxel-based diffusion tensor im-
aging study. Mov. Disord. 25, 1888–1894.
Jones, D.K., Basser, P.J., 2004. “Squashing peanuts and smashing pumpkins”: How noise
distorts diffusion-weighted MR data. Magn. Reson. Med. 52, 979–993.
Jones, D.K., Cercignani, M., 2010. Twenty-ﬁve pitfalls in the analysis of diffusion MRI
data. NMR Biomed. 23, 803–820.
Jones, D.K., Horsﬁeld, M.A., Simmons, A., 1999. Optimal strategies formeasuring diffusion in
anisotropic systems by magnetic resonance imaging. Magn. Reson. Med. 42, 515–525.
Jubault, T., Brambati, S.M., Degroot, C., Kullmann, B., Strafella, A.P., Lafontaine, A.L.,
Chouinard, S., Monchi, O., 2009. Regional brain stem atrophy in idiopathic
Parkinson's disease detected by anatomical MRI. PLoS One 4, e8247.
Karagulle Kendi, A.T., Lehericy, S., Luciana, M., Ugurbil, K., Tuite, P., 2008. Altered diffu-
sion in the frontal lobe in Parkinson disease. AJNR Am. J. Neuroradiol. 29, 501–505.
Kehagia, A.A., Barker, R.A., Robbins, T.W., 2010. Neuropsychological and clinical hetero-
geneity of cognitive impairment and dementia in patients with Parkinson's dis-
ease. Lancet Neurol. 9, 1200–1213.
Kubicki, M., Shenton, M., 2009. Diffusion tensor imaging and its application to schizo-
phrenia and related disorders. In: Johansen-Berg, H., Behrens, T.E.J. (Eds.), Diffu-
sion MRI. Academic Press, London, pp. 251–270.
Lee, J.E., Park, B., Song, S.K., Sohn, Y.H., Park, H.J., Lee, P.H., 2010a. A comparison of gray
and white matter density in patients with Parkinson's disease dementia and de-
mentia with Lewy bodies using voxel-based morphometry. Mov. Disord. 25, 28–34.
Lee, J.E., Park, H.J., Park, B., Song, S.K., Sohn, Y.H., Lee, J.D., Lee, P.H., 2010b. A compara-
tive analysis of cognitive proﬁles and white-matter alterations using voxel-based
diffusion tensor imaging between patients with Parkinson's disease dementia
and dementia with Lewy bodies. J. Neurol. Neurosurg. Psychiatry 81, 320–326.
Mimura, M., Oeda, R., Kawamura, M., 2006. Impaired decision-making in Parkinson's
disease. Parkinsonism Relat. Disord. 12, 169–175.
Modrego, P.J., Fayed, N., Artal, J., Olmos, S., 2011. Correlation of ﬁndings in advanced
MRI techniques with global severity scales in patients with Parkinson disease.
Acad. Radiol. 18, 235–241.
Nieuwenhuis, S., Forstmann, B.U., Wagenmakers, E.J., 2011. Erroneous analyses of interac-
tions in neuroscience: a problem of signiﬁcance. Nat. Neurosci. 14, 1105–1107.
Nishio, Y., Hirayama, K., Takeda, A., Hosokai, Y., Ishioka, T., Suzuki, K., Itoyama, Y.,
Takahashi, S., Mori, E., 2010. Corticolimbic gray matter loss in Parkinson's disease
without dementia. Eur. J. Neurol. 17, 1090–1097.
Owen, A.M., James, M., Leigh, P.N., Summers, B.A., Marsden, C.D., Quinn, N.P., Lange,
K.W., Robbins, T.W., 1992. Fronto-striatal cognitive deﬁcits at different stages of
Parkinson's disease. Brain 115 (Pt 6), 1727–1751.
Owen, A.M., Roberts, A.C., Hodges, J.R., Summers, B.A., Polkey, C.E., Robbins, T.W., 1993.
Contrasting mechanisms of impaired attentional set-shifting in patients with fron-
tal lobe damage or Parkinson's disease. Brain 116 (Pt 5), 1159–1175.
Peran, P., Cherubini, A., Assogna, F., Piras, F., Quattrocchi, C., Peppe, A., Celsis, P., Rascol,
O., Demonet, J.F., Stefani, A., Pierantozzi, M., Pontieri, F.E., Caltagirone, C., Spalletta,
G., Sabatini, U., 2010. Magnetic resonance imaging markers of Parkinson's disease
nigrostriatal signature. Brain 133, 3423–3433.
Pereira, J.B., Ibarretxe-Bilbao, N., Marti, M.J., Compta, Y., Junque, C., Bargallo, N.,
Tolosa, E., in press. Assessment of cortical degeneration in patients with Par-
kinson's disease by voxel-based morphometry, cortical folding, and cortical
thickness. Hum. Brain Mapp.
Reetz, K., Gaser, C., Klein, C., Hagenah, J., Buchel, C., Gottschalk, S., Pramstaller, P.P.,
Siebner, H.R., Binkofski, F., 2009. Structural ﬁndings in the basal ganglia in geneti-
cally determined and idiopathic Parkinson's disease. Mov. Disord. 24, 99–103.
Rolheiser, T.M., Fulton, H.G., Good, K.P., Fisk, J.D., McKelvey, J.R., Scherﬂer, C., Khan,
N.M., Leslie, R.A., Robertson, H.A., 2011. Diffusion tensor imaging and olfactory
identiﬁcation testing in early-stage Parkinson's disease. J. Neurol. 258, 1254–1260.
Rowe, J.B., Hughes, L., Williams-Gray, C.H., Bishop, S., Fallon, S., Barker, R.A., Owen, A.M.,
2010. The val158met COMT polymorphism's effect on atrophy in healthy aging and
Parkinson's disease. Neurobiol. Aging 31, 1064–1068.
Salat, D.H., Lee, S.Y., Yu, P., Setty, B., Rosas, H.D., Grant, P.E., 2009. DTI in development
and aging. In: Johansen-Berg, H., Behrens, T.E.J. (Eds.), Diffusion MRI. Academic
Press, London, pp. 205–326.
Scholz, J., Tomassini, V., Johansen-Berg, H., 2009. Individual differences in white matter
microstructure in the healthy brain. In: Johansen-Berg, H., Behrens, T.E.J. (Eds.),
Diffusion MRI. Academic Press, London, pp. 237–250.
Smith, S., Kindlmann, G., 2009. Cross-subject comparison of local diffusion MRI param-
eters. In: Johansen-Berg, H., Behrens, T.E.J. (Eds.), Diffusion MRI. Academic Press,
London, pp. 147–174.
Smith, S.M., Nichols, T.E., 2009. Threshold-free cluster enhancement: addressing prob-
lems of smoothing, threshold dependence and localisation in cluster inference.
Neuroimage 44, 83–98.
Smith, S.M., Jenkinson, M., Johansen-Berg, H., Rueckert, D., Nichols, T.E., Mackay, C.E.,
Watkins, K.E., Ciccarelli, O., Cader, M.Z., Matthews, P.M., Behrens, T.E., 2006.
Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data.
Neuroimage 31, 1487–1505.
Song, S.K., Sun, S.W., Ramsbottom, M.J., Chang, C., Russell, J., Cross, A.H., 2002. Dys-
myelination revealed through MRI as increased radial (but unchanged axial) diffu-
sion of water. Neuroimage 17, 1429–1436.
Song, S.K., Lee, J.E., Park,H.J., Sohn, Y.H., Lee, J.D., Lee, P.H., 2011. Thepattern of cortical atrophy
in patients with Parkinson's disease according to cognitive status. Mov. Disord. 26,
289–296.
Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R., Goedert, M., 1997.
Alpha-synuclein in Lewy bodies. Nature 388, 839–840.
Vaillancourt, D.E., Spraker, M.B., Prodoehl, J., Abraham, I., Corcos, D.M., Zhou, X.J.,
Comella, C.L., Little, D.M., 2009. High-resolution diffusion tensor imaging in the
substantia nigra of de novo Parkinson disease. Neurology 72, 1378–1384.
1684 C.L. Rae et al. / NeuroImage 62 (2012) 1675–1684Wang, F., Kalmar, J.H., He, Y., Jackowski, M., Chepenik, L.G., Edmiston, E.E., Tie,
K., Gong, G., Shah, M.P., Jones, M., Uderman, J., Constable, R.T., Blumberg,
H.P., 2009. Functional and structural connectivity between the perigenual
anterior cingulate and amygdala in bipolar disorder. Biol. Psychiatry 66,
516–521.
Wheeler-Kingshott, C., Cercignani, M., 2009. About “axial” and “radial” diffusivities.
Magn. Reson. Med. 61, 1255–1260.
Williams-Gray, C.H., Foltynie, T., Brayne, C.E., Robbins, T.W., Barker, R.A., 2007. Evolution
of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 130,
1787–1798.
Williams-Gray, C.H., Evans, J.R., Goris, A., Foltynie, T., Ban, M., Robbins, T.W., Brayne, C.,
Kolachana, B.S., Weinberger, D.R., Sawcer, S.J., Barker, R.A., 2009. The distinct cog-nitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.
Brain 132, 2958–2969.
Witt, K., Daniels, C., Schmitt-Eliassen, J., Kernbichler, J., Rehm, S., Volkmann, J., Deuschl,
G., 2006. The impact of normal aging and Parkinson's disease on response prepara-
tion in task-switching behavior. Brain Res. 1114, 173–182.
Zhan, W., Kang, G.A., Glass, G.A., Zhang, Y., Shirley, C., Millin, R., Possin, K.L.,
Nezamzadeh, M., Weiner, M.W., Marks Jr., W.J., Schuff, N., 2012. Regional alter-
ations of brain microstructure in Parkinson's disease using diffusion tensor imag-
ing. Mov. Disord. 27, 90–97.
Zhang, K., Yu, C., Zhang, Y., Wu, X., Zhu, C., Chan, P., Li, K., 2011. Voxel-based analysis of
diffusion tensor indices in the brain in patients with Parkinson's disease. Eur.
J. Radiol. 77, 269–273.
